Riki Matsumoto Selected Research

Partial Epilepsies (Epilepsy, Partial)

4/2021	Effects of a stable concentration of propofol on interictal high-frequency oscillations in drug-resistant epilepsy.
1/2021	Prescription patterns of antiepileptic drugs for adult patients with newly diagnosed focal epilepsy from 2006 to 2017 in Japan.
3/2019	Interictal Slow and High-Frequency Oscillations: Is it an Epileptic Slow or Red Slow?
1/2019	Hashimoto's Encephalopathy Presenting with Smoldering Limbic Encephalitis.
1/2019	A rational, multispectral mapping algorithm for primary motor cortex: A primary step before cortical stimulation.
10/2018	[Initial Experience of Stereotactic EEG Insertion with Anchor Bolt:Problem Extraction and Improvement of Insertion Accuracy].
8/2018	[A case series of 4 epilepsy patients with promnesia].
11/2017	Frontal Fibers Connecting the Superior Frontal Gyrus to Broca Area: A Corticocortical Evoked Potential Study.
1/2017	High frequency activity overriding cortico-cortical evoked potentials reflects altered excitability in the human epileptic focus.
1/2017	Phasic REM Transiently Approaches Wakefulness in the Human Cortex-A Single-Pulse Electrical Stimulation Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riki Matsumoto Research Topics

Disease

20	Epilepsy (Aura) 01/2022 - 10/2004
19	Partial Epilepsies (Epilepsy, Partial) 04/2021 - 05/2004
9	Seizures (Absence Seizure) 01/2021 - 07/2006
7	Temporal Lobe Epilepsy 01/2019 - 05/2002
5	Myoclonus (Nocturnal Myoclonus) 10/2019 - 07/2006
4	Neoplasms (Cancer) 02/2022 - 04/2014
3	Glioma (Gliomas) 02/2022 - 01/2013
3	Multiple Sclerosis 01/2022 - 07/2007
2	Encephalitis (Encephalitis, Rasmussen) 02/2022 - 10/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2012
2	Drug Resistant Epilepsy 04/2021 - 01/2007
2	Stroke (Strokes) 01/2021 - 01/2012
2	Myasthenia Gravis 02/2020 - 06/2012
2	Brain Neoplasms (Brain Tumor) 11/2017 - 10/2015
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2016 - 01/2013
1	Disease Progression 02/2022
1	Autoimmune Diseases of the Nervous System 02/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2022
1	Neuromyelitis Optica (Devic's Disease) 02/2021
1	Infarction (Infarctions) 02/2021
1	Guillain-Barre Syndrome 11/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2020
1	Quadriplegia (Spastic Quadriplegia) 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Muscle Weakness 02/2020
1	Glycogen Storage Disease XIV 02/2020
1	Neuromuscular Junction Diseases 02/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2019
1	Hashimoto's encephalitis 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Brain Hypoxia (Cerebral Hypoxia) 11/2018
1	Unverricht-Lundborg Syndrome (Disease, Unverricht) 10/2018
1	Inflammation (Inflammations) 10/2017
1	Epileptic Syndromes 10/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2014
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 12/2014
1	Astrocytoma (Pilocytic Astrocytoma) 04/2014
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 04/2014
1	Leukocytosis (Pleocytosis) 01/2014
1	Meningoencephalitis 01/2014

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 07/2020 - 10/2017
4	AntibodiesIBA 02/2022 - 10/2017
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 05/2014
3	Leucine (L-Leucine)FDA Link 02/2022 - 01/2013
3	AutoantibodiesIBA 01/2020 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2014
2	EnzymesIBA 01/2022 - 02/2020
2	Pharmaceutical PreparationsIBA 04/2021 - 10/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 05/2012
2	perampanelIBA 10/2019 - 10/2018
2	SteroidsIBA 01/2019 - 01/2014
2	Valproic Acid (Depakote)FDA LinkGeneric 05/2014 - 07/2005
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2022
1	gamma-Aminobutyric Acid (GABA)IBA 02/2022
1	RibitolIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	cytidine diphosphate ribitolIBA 01/2022
1	Dystroglycans (Dystroglycan)IBA 01/2022
1	ProdrugsIBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 04/2021
1	Methylprednisolone FDA LinkGeneric 02/2021
1	Aquaporins (Water Channels)IBA 02/2021
1	technetium Tc 99m bicisate (Neurolite)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2020
1	pembrolizumabIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 02/2020
1	PhosphoglucomutaseIBA 02/2020
1	AntigensIBA 01/2020
1	Pyruvate Dehydrogenase (Lipoamide)IBA 01/2020
1	InterferonsIBA 08/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 08/2019
1	Natalizumab (Tysabri)FDA Link 08/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	AcidsIBA 10/2018
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Cytochrome P-450 CYP2C19IBA 01/2015
1	Clobazam (HR 376)IBA 01/2015
1	Valosin Containing ProteinIBA 12/2014
1	Prednisolone (Predate)FDA LinkGeneric 09/2014
1	Genetic Markers (Genetic Marker)IBA 06/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2014
1	2,6-dinitrotoluene (DNT)IBA 04/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2014
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2014

Therapy/Procedure

28	Electrodes (Electrode) 01/2022 - 05/2002
7	Therapeutics 01/2022 - 07/2007
2	Immunotherapy 02/2022 - 10/2017
2	Implanted Electrodes 11/2019 - 07/2004
1	Activities of Daily Living (ADL) 10/2019
1	Aftercare (After-Treatment) 01/2019
1	Craniotomy 11/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Vagus Nerve Stimulation 05/2014